Back to Results
First PageMeta Content
Chimeric antigen receptor / Fred Hutchinson Cancer Research Center / Steven Rosenberg / Cancer immunotherapy / Cancer research / Medicine / Cancer organizations / Immune system


T Cell Immunotherapy – Optimizing Trial Design Office of Biotechnology Activities Office of Science Policy National Institutes of Health (NIH) Bethesda, MD September 10-11, 2013
Add to Reading List

Document Date: 2014-03-19 16:23:39


Open Document

File Size: 128,92 KB

Share Result on Facebook

Facility

M.D. Baylor College of Medicine Richard Junghans / National Cancer Institute / M.D. University of Washington Laurence Cooper / Ph.D. University of Pennsylvania Stephen Gottschalk / Slide Presentation California Institute of Technology / Slide Presentation Baylor College of Medicine / M.D. University of Pennsylvania Helen Heslop / M.D. Baylor College of Medicine Daniel Powell / University of California / Ph.D. University of California / /

IndustryTerm

active product / /

MedicalCondition

Cancer / chronic conditions / /

Organization

Memorial Sloan-Kettering Cancer Center / National Cancer Institute / Biotechnology Activities office of Science Policy National Institutes of Health / University of Washington / California Institute of Technology / Optimizing Trial Design Office / University of California / Los Angeles / Medical Center / Baylor College of Medicine / University of Pennsylvania / /

Person

Philip Greenberg / Laurence Cooper / Carl June / Antoni Ribas / Steven Rosenberg / Memorial Sloan-Kettering / Hope Antoni Ribas / Angeles Hans-Peter Kiem / Donald Kohn / M.D. Renier Brentjens / Toxicities Helen Heslop / David Baltimore / Crystal Mackall / Michel Sadelain / Fred Hutchinson / D. Fred Hutchinson / /

ProvinceOrState

California / /

RadioStation

AM 10 / /

Technology

Gene Delivery / Stem Cells / Cell Receptors / Biotechnology / /

SocialTag